FDA releases lists of clinics that got products from pharmacy tied to meningitis outbreak

ATLANTA – The government has released a customer list for the specialty pharmacy at the centre of a national fungal meningitis outbreak.

The Food and Drug Administration on Monday listed the medical practices in each state that got any products since May that were later recalled, and how much each received.

They were all customers of New England Compounding Center of Framingham, Mass. A deadly outbreak of a rare fungal form of meningitis has been tied to steroid shots made by the company since May.

Last month, the company recalled the steroid shots that went to clinics in 23 states. That recall was later expanded to all its products, and the lists show they went to a longer list of states.

___

FDA update: http://www.fda.gov/Drugs/DrugSafety/ucm323431.htm

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.